You are here: » News


Cornea appears to resist infection from novel coronavirus

New findings from researchers at Washington University School of Medicine in St. Louis suggest the eye's cornea can resist infection from the novel coronavirus.

Study confirms Phase III results for uveitis treatment

Glenn J. Jaffe, MD, presents a summary of the results of a confirmatory study on a previous Phase III trial that examined sustained drug delivery for the treatment of uveitis, as well as data on the 36-month results in the second, confirmatory phase 3 study of YUTIQ.

World’s Largest Specialty Clinical Data Registry Reveals Insights into Eye Disease Prevention and Treatment

The IRIS® Registry powered a number of big data studies this year, many of which will be presented at AAO 2020 Virtual, the 124th annual meeting of the American Academy of Ophthalmology. The research findings are now available to view on demand.

Drug-linked endogenous endophthalmitis hospitalizations up

From 2003 to 2016, there was a considerable increase in drug-related endogenous endophthalmitis hospitalizations in the United States, according to a study published online in JAMA Ophthalmology.

Major European research scheme gets €4-billion boost

Last-minute budget increase still leaves the upcoming Horizon Europe programme billions short of campaigners’ hopes.

What to know about diabetic retinopathy

Diabetic retinopathy is blood vessel damage in the retina that happens as a result of diabetes.

US president-elect Joe Biden must quickly restore science to government

The election of Biden and Kamala Harris is a win for facts, research and empathy. Each of these must be deployed to fight the pandemic, combat misinformation, mitigate climate change and rebuild the United States’ global relationships.

Researchers discover undescribed population of neurons that help control eye movements

University of Alabama at Birmingham researchers have discovered a previously undescribed population of neurons that help control our eyes as they view in three-dimensional space.

Genentech provides update on presentations, product portfolio

Chris Brittain, MBBS, BSc, MBA, MRCOphth, vice president and global head of ophthalmology product development for Genentech, provides an overview of the company’s podium presentations from the PDS with ranibizumab to faricimab.

Scientists relieved as Joe Biden wins tight US presidential election

The new president has the opportunity to reverse four years of anti-science policies — but he has a hard road ahead as he inherits a nation divided.

Technique to regenerate optic nerve offers hope for future glaucoma treatment

Scientists have used gene therapy to regenerate damaged nerve fibres in the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the leading causes of blindness worldwide.

Preventing post-cataract surgery endophthalmitis

Adding cefuroxime to the irrigating solution used during cataract surgery appears to be a safe and effective method for reducing the risk of postoperative endophthalmitis, according to researchers who reported their experience with this technique in a recently published retrospective study.

Blindness and sight loss to double by 2050

Blindness and severe vision impairment is predicted to affect almost 900 million people worldwide by 2050—up from around 338 million today, according to a new pre-print study accepted by The Lancet and highlighted on World Sight Day.

Retinal pathologies challenging to image with current technologies

Retinal images acquired using the new Heidelberg High Magnification Module provide high-quality images of the maculae in healthy eyes, but the images of eyes with retinal pathologies have poorer image quality.

Imaging the secret lives of immune cells in the eye

University of Rochester vision scientist Jesse Schallek can barely contain his excitement as he shares time-lapse videos showing immune cells moving through living retinal tissue at the back of an eye.